Sputnik Light
| Vaccine description | |
|---|---|
| Target | SARS-CoV-2 |
| Vaccine type | Viral vector |
| Clinical data | |
| Routes of administration | Intramuscular |
| ATC code | |
| Legal status | |
| Legal status |
|
| Part of a series on the |
| COVID-19 pandemic |
|---|
|
| COVID-19 portal |
Sputnik Light (Russian: Спутник Лайт, romanized: Sputnik Layt or Lajt[1]) is a single dose COVID-19 vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology.[2] It consists of the first dose of the Sputnik V vaccine, which is based on the Ad26 vector, and it can be stored at a normal refrigerator temperature of 2–8 °C (36–46 °F).[3] The institute says this version would be ideally suited for areas with acute outbreaks, allowing more people to be vaccinated quickly.[4] It will also be used as a third (booster) dose for those who received Sputnik V at least 6 months earlier.[5]
- ^ Filipenok A, Gubernatorov E (6 May 2021). "В России зарегистрировали вакцину "Спутник Лайт"" [Sputnik Light vaccine registered in Russia]. RBC (in Russian). Retrieved 7 May 2021.
- ^ "Russia Approves Single-Dose Sputnik Light Covid Vaccine For Use". NDTV Coronavirus. Agence France-Presse. 6 May 2021.
- ^ "Single dose vaccine, Sputnik Light, authorized for use in Russia" (Press release). Russian Direct Investment Fund. 6 May 2021. Retrieved 7 May 2021.
- ^ "Russia authorises single-dose Sputnik Light COVID vaccine for use -RDIF". Reuters. Moscow. 6 May 2021. Retrieved 29 June 2021.
- ^ "Russia launches Sputnik Light vaccine into wide circulation". reuters. Moscow. 29 June 2021. Retrieved 25 June 2021.